Biotechnology Analyst Karnauskas holds a group dinner meeting with Gilead Sciences (GILD) and Arcus Biosciences (RCUS) on January 10 at 6 pm hosted by Truist.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on GILD:
- Truist biotech analyst to hold an industry dinner meeting
- Hookipa Pharma achieves $5M milestone payment from Gilead
- EVOQ to potentially receive $658.5M in Gilead collaboration on immunotherapies
- RBC downgrades Gilead, says drivers need time to play out
- Gilead downgraded to Sector Perform from Outperform at RBC Capital